http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2353990-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1cf2c1ce6de2cd47ef7bd25c62214cdf http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f52086740f302f427f4df239ef8a1ccb |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-38 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-071 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-33 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-38 |
| filingDate | 2009-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1085464eabd7c17110d2052b14caf31 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5c67351745622d7775eebc842b9772c7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e0bcac26113b7df861fed0973bb005b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf0cea23149eb6db062c11aa74d846ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_200c9190e313494fd8db7e8c747dd4fc |
| publicationDate | 2011-03-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2353990-A1 |
| titleOfInvention | ELABORATION OF ARTIFICIAL FABRICS THROUGH TISULAR ENGINEERING USING FIBRINE AND AGAROSE BIOMATERIALS. |
| abstract | Manufacture of artificial tissues byntissue engineering using fibrin biomaterials andnagarosen n n The present invention provides an in vitro method of preparing an artificial tissue, the artificial tissue obtainable by said method, the pharmaceutical composition comprising it and the use of this tissue or of this composition to increase, restore or partially or totally replace the activity. Functional of a damaged tissue or organ, preferably skin, bladder, urethra, cornea, oral mucosa, conjunctiva, abdominal wall, eardrum, pharynx, larynx, intestine, peritoneum, ligament, tendon, bone, meninge or vagina. The method of the invention comprises the steps of adding fibrinogen to isolated cells, preferably to fibroblasts or keratocytes, adding an antifibrinolytic agent to the mixture, further adding a coagulation factor, a source of calcium and thrombin, adding a polysaccharide, preferably agarose , culturing cells, preferably epithelial cells or stem cells of the umbilical cord, in or on the resulting product and inducing the nanostructuring of said product. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022129663-A1 |
| priorityDate | 2009-08-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 337.